| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,675 |
7,472 |
$338K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,961 |
1,776 |
$110K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,013 |
1,681 |
$88K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
909 |
800 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,459 |
2,574 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,453 |
1,132 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
525 |
460 |
$5K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
327 |
302 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
416 |
268 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
54 |
44 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
408 |
366 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
16 |
15 |
$539.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
616 |
558 |
$126.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
30 |
25 |
$56.48 |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
119 |
119 |
$40.80 |
| 81003 |
|
30 |
26 |
$35.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19 |
13 |
$26.88 |